|
| |
Image Results
Loading...
Loading...
RAPAFLO Pages on BioPortfolio:
|
BioPortfolio - Watson Pharmaceuticals, Inc. - RAPAFLO(TM ...
Read RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign ... (http://www .bioportfolio.com/news/RAPAFLO(TM)_(silodosin)_Provides_Rapid_and.html) ...
http://www.bioportfolio.com/news/RAPAFLO(TM)_(silodosin)_Pro...
|
BioPortfolio - Watson Pharmaceuticals, Inc. - Watson Announces ...
7 Apr 2009 ... Read Watson Announces United States Availability of RAPAFLO(TM) (silodosin), ... RAPAFLO(TM) (silodosin), a Novel New Treatment ...
http://www.bioportfolio.com/news/Watson_Announces_United_Sta...
|
BioPortfolio - Kissei Pharmaceutical Co., Ltd
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic ... Watson Announces United States Availability of RAPAFLO(TM) (silodosin), ...
http://www.bioportfolio.com/biocorporate/25317-Kissei_Pharma...
|
BioPortfolio - Retrograde Obturation
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom
...
http://www.bioportfolio.com/indepth/Retrograde_Obturation.ht...
|
BioPortfolio News: Watson Pharmaceuticals, Inc. - Watson Provides ...
Watson management provided an update of market/payer acceptance of recently launched Brand products, including RAPAFLO® for benign prostatic hyperplasia ...
http://www.bioportfolio.com/news/Watson-Provides-Overview-of...
|
BioPortfolio News: BioPortfolio News 2009-05-08
8 May 2009 ... 07:50: RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign ... http:// www.bioportfolio.com/news/RAPAFLO%28TM%29_%28silodosin% ...
http://www.bioportfolio.com/news/2009-05-08.html...
|
BioPortfolio - Alpha-Glucosidases
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's Rapaflo (silodosin) for, Pharma Live: Dec 12 2009 12:13AM Matching: ...
http://www.bioportfolio.com/indepth/Alpha-Glucosidases.html...
| Results from other life science and pharmaceutical sites:
FDA Approves Rapaflo for the Treatment of Symptoms Due to an ...
10 Oct 2008 ... The US Food and Drug Administration today approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...
|
Silodosin (Rapaflo) for benign prostatic hyperplasia.
Silodosin (Rapaflo) for benign prostatic hyperplasia. [No authors listed]. Another alpha1a blocker that claims to be more than just another alpha1 blocker.
...
http://www.ncbi.nlm.nih.gov/pubmed/19122568...
|
Watson Pharmaceuticals, Inc. Release: RAPAFLO(TM) (silodosin ...
11 May 2009 ... RAPAFLO(TM) was developed and is manufactured by Watson Pharmaceuticals, a leader in generic and specialty branded pharmaceuticals. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=139260...
|
DailyMed: About DailyMed
RAPAFLO, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment ..... RAPAFLO is the brand name for silodosin, a selective antagonist
of ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=12598...
|
Watson Pharmaceuticals, Inc. Presented Data Confirm That RAPAFLO ...
RAPAFLO(TM) is a new, uniquely selective alpha blocker for the treatment of the signs and symptoms of BPH, launched earlier this month by Watson ...
http://www.biospace.com/news_story.aspx?NewsEntityId=137198...
|
Benign Prostatic Hyperplasia (BPH) Agents - Pharmacy Clinical ...
NOTE: Avodart, Flomax, Rapaflo and Uroxatral do not require ... Cardura XL, Proscar and Rapaflo are currently listed on the Aetna Formulary Exclusions List.
...
http://www.aetna.com/products/rxnonmedicare/data/2009/GU2009...
|
Watson Pharmaceuticals, Inc. Receives US FDA Approval for RAPAFLO ...
9 Oct 2008 ... "RAPAFLO's approval is the most important milestone for the Company's Brand division thus far," said Paul Bisaro, Chief Executive Officer of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=112418...
|
New drug information: Rapaflo.
1: JAAPA. 2009 Jul;22(7):12. New drug information: Rapaflo. [No authors listed]. PMID: 19697564 [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/19697564...
|
Benign Prostatic Hyperplasia (BPH) Agents - Pharmacy Clinical ...
NOTE: Avodart, Flomax, Rapaflo, tamsulosin and Uroxatral do not require .... Abramowicz M. Silodosin (Rapaflo) for benign prostatic hyperplasia. ...
http://www.aetna.com/products/rxnonmedicare/data/2010/GU2010...
|
Silodosin - Wikipedia, the free encyclopedia
... for silodosin has been accepted for filing. FDA approved this drug on October 9th, 2008. Silodosin is marketed under the tradename Rapaflo. ...
http://en.wikipedia.org/wiki/Silodosin...
|
|
